WHO Downgrades Status of Oseltamivir
Overview
Authors
Affiliations
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.
Punekar M, Kshirsagar M, Tellapragada C, Patil K Microb Pathog. 2022; 168:105608.
PMID: 35654381 PMC: 9160731. DOI: 10.1016/j.micpath.2022.105608.
Oseltamivir Treatment for Influenza During the Flu Season of 2018-2019: A Longitudinal Study.
Li X, Chen J, Wang W, Lin F, Li L, Liang J Front Microbiol. 2022; 13:865001.
PMID: 35620096 PMC: 9127596. DOI: 10.3389/fmicb.2022.865001.
Time for the ethical management of COVID-19 vaccines.
Binagwaho A, Mathewos K, Davis S Lancet Glob Health. 2021; 9(8):e1169-e1171.
PMID: 33961810 PMC: 8096324. DOI: 10.1016/S2214-109X(21)00180-7.
Angus D, Berry S, Lewis R, Al-Beidh F, Arabi Y, van Bentum-Puijk W Ann Am Thorac Soc. 2020; 17(7):879-891.
PMID: 32267771 PMC: 7328186. DOI: 10.1513/AnnalsATS.202003-192SD.
Rosli S, Kirby F, Lawlor K, Rainczuk K, Drummond G, Mansell A Br J Pharmacol. 2019; 176(19):3834-3844.
PMID: 31271646 PMC: 6780046. DOI: 10.1111/bph.14787.